Skip to main content

Table 3 Participant characteristics

From: Co-production of randomized clinical trials with patients: a case study in autologous hematopoietic stem cell transplant for patients with scleroderma

  

n = 278

Percent

Age

18–39 years old

27

10

40–59 years old

120

43

60+

131

47

Gender

Woman

244

88

Man

32

12

Gender fluid, non-binary, and/or Two-Spirit

1

< 1

Prefer not to say

1

< 1

Scleroderma type

Limited

121

44

Diffuse

150

54

Other

7

3

Age at diagnosis

0–18 years old

8

3

18–39 years old

94

34

40–59 years old

141

51

60+

35

13

Disease duration

0–4 years

37

13

5–9 years

77

28

10–19 years

99

36

20–29 years

38

14

30+ years

27

10

Country

Canada

123

44

USA

77

28

France

49

18

UK

21

8

Côte d’Ivoire

1

< 1

Zambia

1

< 1

Identification*

Aboriginal or indigenous

22

8

African American or Black

8

3

Asian

7

3

Caucasian

206

74

Hispanic or Latino(a)

10

4

South Asian

3

1

How I identify is not listed here

23

8

Prefer not to say

4

1

  1. *Respondents could choose multiple categories